XML 26 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Options
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Options
Stock Options

The following table summarizes stock option activity in the Company’s stock-based compensation plans for the year ended December 31, 2017. All options issued were non-qualified stock options.
 
Number of
Options
 
Weighted Average
Exercise Price
 
Aggregate
Intrinsic Value (1)
 
Number of
Options Exercisable
 
Weighted Average Fair Value At
Date of Grant
Outstanding at December 31, 2015
37,636

 
$
12.01

 
$

 
18,665

 
13.59
Granted at Fair Value

 
$

 


 


 

Exercised

 

 


 


 

Canceled
(9,870
)
 
$
10.72

 


 


 

Outstanding at December 31, 2016
27,766

 
$
12.47

 
$

 
21,187

 
13.16
Granted at Fair Value
197,369

 
$
1.52

 

 


 

Exercised

 

 

 

 

Canceled
(1,579
)
 
$
38

 

 


 

Outstanding at December 31, 2017
223,556

 
$
2.62

 
$
489,475

 
44,827

 
13.49

 
(1)
The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option at December 31, 2017. If the exercise price exceeds the market value, there is no intrinsic value.

During the year ended December 31, 2017, the Company did not grant employee stock options or stock options for consulting services.

The fair value of the stock option grants are amortized over the respective vesting period using the straight-line method and assuming no forfeitures and cancellations.

Compensation expense related to stock options included in general and administrative expense in the accompanying statements of operations for the years ended December 31, 2017 and 2016, was $312,351, and $86,733, respectively.
 
Stock options are granted at the fair market value of the Company’s common stock on the date of grant. Options granted to officers and other employees vest immediately or over 36 months as provided in the option agreements at the date of grant.

The fair value of each option granted in 2017 and 2016 was estimated using the Black-Scholes Option Pricing Model. The following assumptions were used to compute the weighted average fair value of options granted during the periods presented.
 
 
2017
 
2016
Expected term of option
10 years

 
3 years

Risk free interest rates
2.18
%
 
1.12
%
Estimated volatility
972.1

 
593.3

Dividend yield
%
 
%

 
The following table summarizes information about stock options outstanding at December 31, 2017:

Range of
Exercise Prices
Number of
Options
Weighted
Average
Remaining
Contractual
Life (Years)
Weighted
Average
Exercise
Price
Aggregate
Intrinsic
Value (1)
Number
Exercisable
Weighted Average Exercise
Price of Exercisable Options
Aggregate
Intrinsic
Value (1)
$1.52- $13.30
223,556

9.04
$
2.62

$
489,475

44,827

$
13.49

$
54,386


(1)
The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option at December 31, 2017. If the exercise price exceeds the market value, there is no intrinsic value. 

The following table summarizes information about options outstanding at December 31, 2016:
Range of
Exercise Prices
Number of
Options
Weighted
Average
Remaining
Contractual
Life (Years)
Weighted
Average
Exercise
Price
Aggregate
Intrinsic
Value (1)
Number
Exercisable
Weighted
Average
Exercise
Price of Exercisable Options
Aggregate
Intrinsic
Value (1)
$10.26-$38.00
27,766

5.25
$
12.47

$

21,187

$
13.16

$



A summary of the Company’s non-vested stock options at December 31, 2017 and December 31, 2016 and changes during the years are presented below.
 
Non-Vested Stock Options
Options
 
Weighted Average
Grant Date
Fair Value
Non-Vested at December 31, 2016
6,579

 
$
10.26

Granted
197,369

 
$
1.52

Vested
(25,220
)
 
$
2.66

Forfeited

 
$

Non-Vested at December 31, 2017
178,728

 
$
1.68